SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on August 13, 2025. The filing discloses the entry into a material definitive agreement regarding the amendment of a previously announced secured convertible debenture purchase agreement with YA II PN, LTD. (Yorkville).
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, or operating margins. The primary financial data disclosed relates to the capital structure of the new financing arrangement:
- First Secured Convertible Debenture: $25,000,000 principal amount.
- Second Secured Convertible Debenture: $25,000,000 principal amount.
- Additional Potential Debentures: Up to $50,000,000 aggregate principal amount, subject to mutual agreement.
- Conversion Floor Price: Set at 20% of the Nasdaq Official Closing Price immediately prior to the date of entry into the original Debenture Purchase Agreement.
Material Changes
The filing details a material amendment to the Debenture Purchase Agreement originally entered on July 7, 2025. Key changes include:
- Restructuring the transaction into two initial debentures of $25 million each, with an option for up to $50 million in additional debentures.
- Modification of purchase, closing, and stockholder approval provisions.
- Establishment of a specific floor price for conversions to protect against excessive dilution.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or a discussion of general business risks. The primary contingency noted is that the issuance of the additional $50,000,000 in debentures is discretionary and requires mutual agreement, which may be withheld by either party at their sole discretion.
Investor Verification Checklist
- Verify the full text of the Amendment to the Secured Convertible Debenture Purchase Agreement (Exhibit 10.1) for specific covenants and default provisions.
- Confirm the exact Nasdaq Official Closing Price used to calculate the 20% conversion floor price.
- Review the status of stockholder approval requirements mentioned as modified in the amendment.
- Assess the impact of the potential $100 million total debt obligation on the company's existing liquidity and capital structure.